全文获取类型
收费全文 | 53319篇 |
免费 | 4344篇 |
国内免费 | 541篇 |
学科分类
医药卫生 | 58204篇 |
出版年
2024年 | 47篇 |
2023年 | 1003篇 |
2022年 | 1549篇 |
2021年 | 2540篇 |
2020年 | 3207篇 |
2019年 | 2039篇 |
2018年 | 1888篇 |
2017年 | 1971篇 |
2016年 | 2056篇 |
2015年 | 2036篇 |
2014年 | 4735篇 |
2013年 | 4518篇 |
2012年 | 4093篇 |
2011年 | 4057篇 |
2010年 | 3325篇 |
2009年 | 2745篇 |
2008年 | 2793篇 |
2007年 | 2553篇 |
2006年 | 2318篇 |
2005年 | 1806篇 |
2004年 | 1461篇 |
2003年 | 1147篇 |
2002年 | 812篇 |
2001年 | 629篇 |
2000年 | 539篇 |
1999年 | 385篇 |
1998年 | 351篇 |
1997年 | 291篇 |
1996年 | 227篇 |
1995年 | 149篇 |
1994年 | 149篇 |
1993年 | 132篇 |
1992年 | 76篇 |
1991年 | 93篇 |
1990年 | 64篇 |
1989年 | 54篇 |
1988年 | 46篇 |
1987年 | 41篇 |
1986年 | 31篇 |
1985年 | 51篇 |
1984年 | 36篇 |
1983年 | 32篇 |
1982年 | 30篇 |
1981年 | 27篇 |
1980年 | 19篇 |
1979年 | 14篇 |
1978年 | 13篇 |
1977年 | 4篇 |
1976年 | 11篇 |
1974年 | 7篇 |
排序方式: 共有10000条查询结果,搜索用时 578 毫秒
1.
2.
以“七麦数据”网站收录的中医移动医疗App作为研究对象,采用网络调查法和文献分析法,根据“七麦数据”对移动医疗App的分类,结合中医移动医疗App的信息服务内容和特点,将筛选出的中医移动医疗App划分为医疗健康类、中医养生类、知识传播类、全面综合类,并根据“七麦数据”网站中对各类中医移动医疗App的打分及累计下载量筛选出最具代表性的12款中医移动医疗App,从全面性、人性化、安全性、实用性4个一级指标和40个二级指标对其信息服务现状进行评价,指出当前中医移动医疗App信息服务存在的问题并提出建议。 相似文献
3.
4.
5.
6.
目的研究风险管理在儿科急诊护理工作中的应用。方法选取2021年10月至12月间来我科室就诊的100例患儿作为研究对象,将其分为研究组、对照组两组,每组各50例患儿。运用常规护理模式护理对照组患儿,运用风险管理模式,为研究组患儿给予护理干预,分析二组发生不良护理事故的情况并统计护理满意度。结果研究期间,研究组不良护理事件发生率为2.0%,对照组不良护理事件发生率为12.0%;研究组对护理工作的满意度为98.0%,对照组对护理工作的满意度为84.0%,P<0.05,组间差异具统计学意义。结论将风险管理应用于儿科急诊护理工作,可降低不良事件发生几率,保障患儿安全,具有推广应用价值。 相似文献
7.
《Journal of Radiology Nursing》2022,41(2):123-128
ObjectiveThe objective of this study was to reduce errors in a pathologic specimen with the help of a protocol systematizing the pathology specimen management process in the operating room.Materials and methodThis quasi-experimental study was carried out in the operating room unit of a research and training hospital. A protocol systematizing the process of specimen management in secure surgical pathology and prepared in light of the current literature was used as an intervention, and the effectiveness of the protocol was tested.ResultsIt was determined that the rate of adverse events decreased from .3226% (68 of 21,078) to .032% (6 of 18,706) after the protocol systematizing the surgical pathology specimen management process prepared by the researchers, and the protocol was found to be effective by 90% (P = .03).ConclusionBased on the data obtained in this study, we recommend the use of a pathologic specimen management protocol in the operating room. 相似文献
8.
9.
Michael Staehler Peter J. Goebell Lothar Müller Till-Oliver Emde Natalie Wetzel Lisa Kruggel Martina Jänicke Norbert Marschner the RCC-Registry Group 《International journal of cancer. Journal international du cancer》2020,146(5):1307-1315
Non-clear cell renal cell carcinoma is a very rare malignancy that includes several histological subtypes. Each subtype may need to be addressed separately regarding prognosis and treatment; however, no Phase III clinical trial data exist. Thus, treatment recommendations for patients with non-clear cell metastatic RCC (mRCC) remain unclear. We present first prospective data on choice of first- and second-line treatment in routine practice and outcome of patients with papillary mRCC. From the prospective German clinical cohort study (RCC-Registry), 99 patients with papillary mRCC treated with systemic first-line therapy between December 2007 and May 2017 were included. Prospectively enrolled patients who had started first-line treatment until May 15, 2016, were included into the outcome analyses (n = 82). Treatment was similar to therapies used for clear cell mRCC and consisted of tyrosine kinase inhibitors, mechanistic target of rapamycin inhibitors and recently checkpoint inhibitors. Median progression-free survival from start of first-line treatment was 5.4 months (95% confidence interval [CI], 4.1–9.2) and median overall survival was 12.0 months (95% CI, 8.1–20.0). At data cutoff, 73% of the patients died, 6% were still observed, 12% were lost to follow-up, and 9% were alive at the end of the individual 3-year observation period. Despite the lack of prospective Phase III evidence in patients with papillary mRCC, our real-world data reveal effectiveness of systemic clear cell mRCC therapy in papillary mRCC. The prognosis seems to be inferior for papillary compared to clear cell mRCC. Further studies are needed to identify drivers of effectiveness of systemic therapy for papillary mRCC. 相似文献
10.